Genekam has formed a new company called
3D Genome Medicine Inc. in order to start operations in USA. Shortly website and adress!
Genekam Biotechnology AG is going to add UDI code (Unique Device Identification) to its CE marked kits shortly
Genekam is developing complex solutions based on antibody conjugates for therapeutic and diagnostic use. The antibodies can be recombinant as well as monoclonal type. Conjugates will be based on beyond the state of art technology. Some of conjugates may have potential to be used as vaccines also.